3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma, Non-Hodgkin
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Myelodysplastic Syndromes
3
Leukemia, Myeloid, Acute
3
Primary Myelofibrosis
2
Ovarian Neoplasms
2
Myeloproliferative Disorders
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Hodgkin Disease
2
Triple Negative Breast Neoplasms
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Neoplasms
1
Mesothelioma, Malignant
1
Mesothelioma
1
Leukemia, Prolymphocytic, B-Cell
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Biphenotypic, Acute
1
Kidney Neoplasms
1
Glioma
1
Fallopian Tube Neoplasms
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Burkitt Lymphoma
1
Interventions
Specimen Handling
53
pembrolizumab
51
Carboplatin
51
Magnetic Resonance Spectroscopy
46
Pemetrexed
41
Cisplatin
36
Paclitaxel
25
durvalumab
24
osimertinib
22
Nivolumab
22
Gemcitabine
20
Radiosurgery
18
Radiotherapy
17
Docetaxel
17
atezolizumab
15
Immunoglobulin G
15
Biopsy
15
Disulfides
14
130-nm albumin-bound paclitaxel
13
Taxes
12
Radiation
12
Educational Status
12
Etoposide
11
Blood Specimen Collection
11
Early Intervention, Educational
10
Drug Therapy
10
Practice Guidelines as Topic
9
Platinum
9
Methods
9
Cetuximab
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lung Neoplasms
×
Blood Component Removal
×
90 days
×
Clear all
No trials found.